5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice

Oxaliplatin causes peripheral neuropathy as a major dose-limiting side effect, and the control of this neuropathy is difficult. This study was designed to investigate whether prophylactic repetitive administration of 5-HT1A receptor agonists inhibits oxaliplatin-induced mechanical allodynia in mice....

Full description

Bibliographic Details
Main Authors: Tsugunobu Andoh, Ayumi Sakamoto, Yasushi Kuraishi
Format: Article
Language:English
Published: Elsevier 2016-08-01
Series:Journal of Pharmacological Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861316300901
id doaj-b04d92f98c254652969c07d3f1d8acff
record_format Article
spelling doaj-b04d92f98c254652969c07d3f1d8acff2020-11-24T21:32:00ZengElsevierJournal of Pharmacological Sciences1347-86132016-08-01131428428710.1016/j.jphs.2016.07.0085-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated miceTsugunobu Andoh0Ayumi Sakamoto1Yasushi Kuraishi2Department of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, JapanDepartment of Applied Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, JapanResearch Administration Division, Tokyo Medical and Dental University, Tokyo 113-8510, JapanOxaliplatin causes peripheral neuropathy as a major dose-limiting side effect, and the control of this neuropathy is difficult. This study was designed to investigate whether prophylactic repetitive administration of 5-HT1A receptor agonists inhibits oxaliplatin-induced mechanical allodynia in mice. Repetitive administration of 5-HT1A receptor agonists (xaliproden and tandospirone) inhibited mechanical allodynia induced by a single intraperitoneal injection of oxaliplatin. These agonists also inhibited oxaliplatin-induced mast cell migration, which is involved in the induction of mechanical allodynia. These results suggest that the prophylactic repetitive administration of 5-HT1A receptor agonists attenuates oxaliplatin-induced mechanical allodynia by inhibiting the cutaneous mast cell migration.http://www.sciencedirect.com/science/article/pii/S1347861316300901XaliprodenTandospironeMast cells
collection DOAJ
language English
format Article
sources DOAJ
author Tsugunobu Andoh
Ayumi Sakamoto
Yasushi Kuraishi
spellingShingle Tsugunobu Andoh
Ayumi Sakamoto
Yasushi Kuraishi
5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice
Journal of Pharmacological Sciences
Xaliproden
Tandospirone
Mast cells
author_facet Tsugunobu Andoh
Ayumi Sakamoto
Yasushi Kuraishi
author_sort Tsugunobu Andoh
title 5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice
title_short 5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice
title_full 5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice
title_fullStr 5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice
title_full_unstemmed 5-HT1A receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice
title_sort 5-ht1a receptor agonists, xaliproden and tandospirone, inhibit the increase in the number of cutaneous mast cells involved in the exacerbation of mechanical allodynia in oxaliplatin-treated mice
publisher Elsevier
series Journal of Pharmacological Sciences
issn 1347-8613
publishDate 2016-08-01
description Oxaliplatin causes peripheral neuropathy as a major dose-limiting side effect, and the control of this neuropathy is difficult. This study was designed to investigate whether prophylactic repetitive administration of 5-HT1A receptor agonists inhibits oxaliplatin-induced mechanical allodynia in mice. Repetitive administration of 5-HT1A receptor agonists (xaliproden and tandospirone) inhibited mechanical allodynia induced by a single intraperitoneal injection of oxaliplatin. These agonists also inhibited oxaliplatin-induced mast cell migration, which is involved in the induction of mechanical allodynia. These results suggest that the prophylactic repetitive administration of 5-HT1A receptor agonists attenuates oxaliplatin-induced mechanical allodynia by inhibiting the cutaneous mast cell migration.
topic Xaliproden
Tandospirone
Mast cells
url http://www.sciencedirect.com/science/article/pii/S1347861316300901
work_keys_str_mv AT tsugunobuandoh 5ht1areceptoragonistsxaliprodenandtandospironeinhibittheincreaseinthenumberofcutaneousmastcellsinvolvedintheexacerbationofmechanicalallodyniainoxaliplatintreatedmice
AT ayumisakamoto 5ht1areceptoragonistsxaliprodenandtandospironeinhibittheincreaseinthenumberofcutaneousmastcellsinvolvedintheexacerbationofmechanicalallodyniainoxaliplatintreatedmice
AT yasushikuraishi 5ht1areceptoragonistsxaliprodenandtandospironeinhibittheincreaseinthenumberofcutaneousmastcellsinvolvedintheexacerbationofmechanicalallodyniainoxaliplatintreatedmice
_version_ 1725958945737015296